ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)
| 13.42 Data as of May 22 |  -0.37 / -2.68%Today’s Change | 1.30 Today|||52-Week Range 14.75 | +188.60% Year-to-Date |
Latest ACAD News | Press Releases
| Hey 19 May 21 / TheStreet.com | Small-Caps Out Front May 20 / TheStreet.com |
| The Most Hated Breakout Ever May 21 / TheStreet.com | Trumping Market Skepticism May 20 / TheStreet.com |
| Clean-Up Time May 21 / TheStreet.com | Sailing on a Sea of Liquidity May 15 / TheStreet.com |
| Why Keryx is Lagging But Acadia is Zooming (Hint: It's About NCE) May 21 / TheStreet.com | Back to the Future? May 15 / TheStreet.com |
| Slightly Negative but Still Frothy May 20 / TheStreet.com | What's On My Radar May 15 / TheStreet.com |
Today’s Trading
| Previous close | 13.79 |
| Today’s open | 13.84 |
| Day’s range | 13.18 - 14.20 |
| Volume | 2,361,305 |
| Average volume (3 months) | 3,839,216 |
| Market cap | $1.2B |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/22/2013
Growth & Valuation
| Earnings growth (last year) | +13.64% |
| Earnings growth (this year) | +20.18% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +137.40% |
| P/E ratio | NM |
| Price/Sales | 52.23 |
| Price/Book | 11.90 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PDLIPDL BioPharma Inc | -0.11 | -1.31% |
| SRPTSarepta Therapeutics... | -0.33 | -0.90% |
| TSROTESARO Inc | -1.05 | -2.94% |
| INFIInfinity Pharmaceuti... | -2.01 | -8.00% |
Data as of 4:00pm ET, 05/22/2013
Financials
| Next reporting date | August 6, 2013 |
| EPS forecast (this quarter) | -$0.02 |
| Annual revenue (last year) | $4.9M |
| Annual profit (last year) | -$20.8M |
| Net profit margin | -424.88% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Uli Hacksell, PhD |
Treasurer, Chief Financial & Business Officer Thomas H. Aasen, CPA |
Corporate headquarters San Diego, California |
Forecasts
